JB Chemicals, KKR
JB Chemicals, KKR
Dealstreet

SAM, Platinum, Simpson Thacher act on KKR 54% acquisition of JB Chemicals for Rs 3,100 crore

Bar & Bench

US private equity giant KKR is acquiring about 54 per cent stake in Mumbai-based drug manufacturer JB Chemicals & Pharmaceuticals, one of the oldest pharma companies in India, for Rs 3,100 crore.

Shardul Amarchand Mangaldas acted for KKR and the team was led by Partner Raghubir Menon along with Partner Anirban Bhattacharya, Principal Associate Taranjeet Singh, Senior Associates Swati Sharma and Neelam Pathak and Associate Tanmayee Chaulker.

Partner Yogesh Chande, Kanwardeep Kapany and Preeti Kapany advised on regulatory aspect.

Partner Aparna Mehra along with Principal Associate Aman Sethi and Associates Abhiruchi Jhawar, Saumya Raizada and Ritika Sood advised on competition law aspect.

Bar and Bench - Indian Legal news
www.barandbench.com